Skip to main content
VCbacked
Log inGet Started

Shennon Biotechnologies

San Francisco, United States

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

$13.0M raised
Mar 2023
Seed
BiotechnologyLife ScienceMedical

Top Investors

Foundation CapitalDCVCAV8 VenturesJasper LauMei Z.

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shennon Biotechnologies

How much funding has Shennon Biotechnologies raised?
Shennon Biotechnologies has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Who are Shennon Biotechnologies's investors?
Shennon Biotechnologies's investors include Foundation Capital, DCVC, AV8 Ventures, Jasper Lau, Mei Z..
Where is Shennon Biotechnologies headquartered?
Shennon Biotechnologies is headquartered in San Francisco, United States.
What does Shennon Biotechnologies do?
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
What stage is Shennon Biotechnologies at?
Shennon Biotechnologies is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Shennon Biotechnologies — Funding & Investors." VCBacked, March 13, 2023, https://www.vcbacked.co/company/shennon-biotechnologies. Accessed June 4, 2026.
APA
VCBacked. (2023). Shennon Biotechnologies — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/shennon-biotechnologies
Wikipedia (cite web)
{{cite web |title=Shennon Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/shennon-biotechnologies |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong